The development of new antibiotics to treat superbugs and other bacterial infections is a global priority, with the rate of infections that cannot be treated with current antibiotics rising and ...

Skin microbes do more than coexist—they shape immune responses, repair tissue, and influence gene expression across your ...

Background: Methicillin-resistant Staphylococcus aureus (MRSA ... as all patient-identifiable information was removed during the experimental process. The antibiotic resistance characteristics of 115 ...

The last time a new class of antibiotics reached the market was nearly three decades ago—but that could soon change, thanks to a discovery by researchers at McMaster University. The discovery of ...

It is the first in a new class of oral antibiotics approved for this condition in nearly 30 years. UTIs are common bladder infections that typically affect women without underlying health issues.

UIC researchers working with collaborators at McMaster University in Canada determined how the new antibiotic works and why the drug evades bacterial resistance. "The holy grail in the field is to ...

Researchers have discovered a new antibiotic molecule that targets a broad range of disease-causing bacteria — even strains resistant to commercial drugs — and is not toxic to human cells 1.

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

The Food and Drug Administration on Tuesday approved the first drug in a new class of antibiotics for treating urinary tract infections — the first time that’s happened in nearly 30 years.

Gepotidacin is the first new class of oral antibiotics for uUTIs in nearly 30 years, addressing rising drug resistance. Phase 3 trials showed gepotidacin's non-inferiority to nitrofurantoin ...